{"entity":{"id":"nct06522828","kind":"trial","name":"A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients","aka":[],"tldr":"A phase 2 trial of PF-08634404, Carboplatin, Paclitaxel / nab-paclitaxel in endometrial cancer and ovarian cancer, run by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., now recruiting.","summary":"A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients is a phase 2 interventional study registered as NCT06522828 by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., with 80 participants planned, started 2024-10-10 and due to reach its primary completion in 2025-08. Interventions recorded: SSGJ-707, carboplatin, paclitaxel. Conditions listed: Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06522828","url":"https://clinicaltrials.gov/study/NCT06522828"}],"tags":["ctgov-ingest"],"related":[],"cancers":["endometrial","ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":["pf-08634404","carboplatin","paclitaxel"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06522828","phase":"2","setting":"A Phase 2 Study to Evaluate the Safety and Efficacy of SSGJ-707 in Advanced Gynecologic Cancer Patients","sponsor":"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.","enrolled":80,"outcomes":[]},"route":"/trials/nct06522828/","neighbours":{"cancer":[{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"},{"id":"pf-08634404","kind":"drug","name":"PF-08634404","route":"/drugs/pf-08634404/"}]}}